Last updated: September 23, 2026
Ferric oxide red, also called red iron oxide or CI 77491, is a mature inorganic pigment used as a pharmaceutical colorant, cosmetic ingredient, food-coloring component in certain jurisdictions, and industrial pigment. The global iron oxide pigment market is estimated by commercial research firms at roughly $2.5 billion to $3.5 billion annually, but pharmaceutical-grade ferric oxide red is not reported as a separate public market segment. Its direct pharmaceutical revenue is therefore much smaller and is driven by tablet volumes, color-standard requirements, regulatory qualification, and supplier reliability rather than by novel-product pricing.
The market outlook is stable to moderately positive. Volume growth is tied to generic and branded oral-solid-dose manufacturing, while revenue growth depends on high-purity grades, documentation, low-heavy-metal specifications, and supply contracts. Industrial construction and coatings remain the dominant end markets and have a much greater effect on pigment producers than pharmaceutical demand.
What is ferric oxide red and how is it used in pharmaceuticals?
Ferric oxide red is predominantly hematite-phase iron(III) oxide, with the chemical formula Fe2O3. It is identified by Color Index International as CI 77491 and is commonly listed in pharmaceutical formulations as ferric oxide red, red iron oxide, or synthetic iron oxide.
In pharmaceuticals, it is primarily used as:
- A tablet and capsule colorant
- A coating pigment
- A visual differentiator between strengths or dosage forms
- A light-shielding or appearance-modifying ingredient
- An ingredient in chewable, orally disintegrating, and multiparticulate products
Ferric oxide red is not an active pharmaceutical ingredient. It does not provide therapeutic efficacy and usually represents a very small portion of a finished product’s bill of materials. Its commercial value comes from consistent color, particle-size distribution, dispersion, purity, and regulatory documentation.
Typical pharmaceutical applications include film-coated tablets, hard capsules, granules, pellets, and selected topical products. The pigment can be used alone or blended with titanium dioxide, yellow iron oxide, black iron oxide, lakes, or other permitted colorants.
How large is the ferric oxide red pharmaceutical market?
No major pigment producer publicly reports revenue specifically for pharmaceutical-grade ferric oxide red. Public market reports generally combine synthetic and natural iron oxides across construction materials, coatings, plastics, ceramics, cosmetics, food, and pharmaceuticals.
| Market measure |
Publicly supportable assessment |
| Global iron oxide pigment market |
Approximately $2.5 billion to $3.5 billion in recent commercial estimates |
| Pharmaceutical share |
Not separately disclosed; likely a low-single-digit portion of total pigment demand |
| Pharmaceutical ferric oxide red revenue |
No audited public market total |
| Main revenue pool |
Construction, coatings, plastics, and concrete coloration |
| Pharmaceutical growth profile |
Low-to-mid single-digit volume growth in a base case |
| Pricing profile |
Commodity-to-specialty, depending on grade and documentation |
| Main purchasing criterion |
Consistency and qualification, not lowest nominal price |
Pharmaceutical demand is structurally smaller than industrial demand but has stronger qualification barriers. A drug manufacturer cannot normally replace one supplier with another without assessing specifications, regulatory files, color matching, process performance, and change-control requirements.
That qualification burden supports supplier retention and can protect margins on pharmaceutical grades. It does not create the pricing power associated with an active ingredient or a patented drug.
What is driving ferric oxide red market growth?
Generic oral-solid-dose production
Generic tablets and capsules account for a large share of pharmaceutical ferric oxide red consumption. Every additional strength, product line, or geographic presentation can require a distinct coating color. Growth in generic medicines, contract manufacturing, and emerging-market oral dosage production supports steady pigment demand.
Branded product differentiation
Branded pharmaceutical companies use color to distinguish dosage strengths, improve product recognition, and support packaging and adherence programs. Color consistency becomes important when products are sold across multiple manufacturing sites.
Outsourced manufacturing
Contract development and manufacturing organizations increasingly produce tablets and capsules for multiple sponsors. This favors suppliers that can provide global documentation, standardized batches, technical support, and reliable delivery.
Regulatory scrutiny of colorants
Regulatory scrutiny increases the value of suppliers that can document identity, purity, elemental impurities, microbiological quality, and manufacturing controls. Ferric oxide red is a relatively established ingredient, but pharmaceutical buyers still require controlled specifications and change notifications.
Cosmetic and nutraceutical overlap
The same pigment grades can be sold into cosmetics, personal care, nutraceuticals, and pharmaceutical products, subject to differing specifications. Growth in color cosmetics provides a secondary demand source, although pharmaceutical applications generally require more extensive quality documentation.
What factors are limiting market growth?
Ferric oxide red faces several structural constraints.
First, usage per tablet is low. A formulation may use only a fraction of a percent of pigment, limiting the value of each finished dosage unit. Second, color substitution is possible in many formulations. A manufacturer may redesign a coating using another iron oxide shade or a different permitted colorant if supply or pricing becomes unfavorable.
Third, the pharmaceutical market is exposed to the broader iron oxide supply chain. Pigment producers may prioritize higher-volume construction, coatings, and plastics customers during periods of plant disruption or feedstock pressure.
Fourth, regulatory requirements differ by jurisdiction. A grade accepted for an industrial application may not meet pharmaceutical or cosmetic requirements. The producer must maintain distinct documentation, testing, and change-control processes.
How does ferric oxide red pricing work?
Ferric oxide red has a broad price range because “iron oxide red” describes multiple quality levels. Industrial pigment pricing is generally lower than pharmaceutical-grade pricing. Pharmaceutical buyers pay for:
- Narrow color and particle-size specifications
- Low levels of heavy metals and other elemental impurities
- Batch-to-batch uniformity
- GMP-compatible manufacturing controls
- Certificates of analysis and regulatory statements
- Stability and compatibility data
- Auditable supply-chain and change-control systems
- Small-lot packaging and technical support
The pigment itself is usually not a major cost driver in a tablet. Excipients, active pharmaceutical ingredients, coating polymers, packaging, quality testing, and manufacturing labor generally have greater effects on unit economics.
Pricing power is therefore limited in standard grades but stronger in qualified specialty grades. A supplier can defend pricing when switching would require reformulation, color requalification, regulatory filing updates, or site validation.
Which companies supply ferric oxide red?
The competitive field includes large inorganic-pigment producers, specialty color manufacturers, and pharmaceutical excipient distributors. Relevant global pigment companies include LANXESS, Cathay Industries, Venator, and other regional manufacturers. Pharmaceutical buyers may purchase directly from a pigment producer or through a specialty excipient distributor.
| Supplier category |
Competitive advantage |
Main limitation |
| Large global pigment producer |
Scale, geographic coverage, broad color portfolio |
Pharmaceutical revenue is usually not separately prioritized |
| Specialty color manufacturer |
Formulation support and pharmaceutical documentation |
Smaller production footprint |
| Excipient distributor |
Local inventory, customer service, regulatory support |
Dependence on upstream producer |
| Regional producer |
Cost and proximity |
More limited global qualification and redundancy |
Supplier competition is based on more than pigment shade. Buyers assess technical data, manufacturing-site history, auditability, regional registration support, and the supplier’s ability to maintain the same material over the product lifecycle.
What is the financial trajectory for ferric oxide red?
The likely trajectory is steady rather than high growth.
| Scenario |
Volume outlook |
Pricing outlook |
Financial result |
| Downside |
Weak construction and coatings demand; flat pharmaceutical volumes |
Feedstock pressure with limited pass-through |
Margin compression |
| Base case |
Low-to-mid single-digit pharmaceutical volume growth |
Moderate inflation-linked increases |
Stable revenue growth and modest margin expansion |
| Upside |
Strong generic production, cosmetics demand, and premium-grade adoption |
Better pass-through for qualified grades |
Above-market growth for specialty suppliers |
Large producers are financially more sensitive to industrial cycles than to pharmaceutical demand. Construction, concrete, coatings, and plastics determine capacity utilization and feedstock economics. Pharmaceutical demand contributes stability because it is less cyclical and more qualification-dependent, but it is unlikely to transform the earnings profile of a major pigment producer.
Specialty suppliers may achieve higher margins than bulk pigment manufacturers because they sell documentation, consistency, inventory availability, and technical support. Their addressable market is smaller, but customer retention can be stronger.
What regulatory status does ferric oxide red have?
Ferric oxide red is used as a permitted colorant in pharmaceutical and cosmetic products under applicable national rules. In the United States, iron oxides are addressed under the FDA color-additive framework, including 21 C.F.R. § 73.1200. The FDA Inactive Ingredient Database also records ferric oxide-related inactive ingredients used in approved drug products.
Regulatory status depends on the product route and jurisdiction. A supplier must distinguish among:
- Oral pharmaceutical use
- Topical pharmaceutical use
- Cosmetic use
- Food use
- Industrial use
European Union food and pharmaceutical colorant treatment commonly refers to iron oxides under E172, subject to applicable specifications and use restrictions. The United States, European Union, Japan, and other markets may differ in permitted applications, labeling, impurity limits, and documentation expectations.
A manufacturer should not treat an industrial “iron oxide red” specification as interchangeable with a pharmaceutical excipient specification.
What patent protection covers ferric oxide red?
Ferric oxide red is a mature chemical substance and is not normally protected by a meaningful composition-of-matter patent estate. Commercial protection primarily comes from know-how, manufacturing controls, particle engineering, color matching, customer qualification, and regulatory files.
Potentially protectable areas include:
- Pigment particle-size engineering
- Surface treatment or coating technology
- Dispersion systems
- Tablet-film formulations
- Color-matching processes
- Manufacturing methods that reduce impurities
- Drug-specific coating compositions
These rights generally protect a formulation or process rather than ferric oxide red itself. Ferric oxide red is not ordinarily associated with Orange Book listings, Paragraph IV challenges, or standalone generic-drug litigation. Patent risk arises when the pigment is incorporated into a patented pharmaceutical formulation or delivery system.
What manufacturing and supply-chain risks affect the market?
The principal risks are operational rather than patent-driven.
Feedstock and energy costs
Iron salts, iron-bearing raw materials, acids, energy, and waste-treatment requirements affect production economics. Energy-intensive calcination and processing can pressure margins when producers cannot pass through cost increases.
Geographic concentration
The global market includes major production capacity in Europe, China, India, and other industrial regions. Pharmaceutical customers increasingly seek dual sourcing and regional inventory to reduce disruption risk.
Batch consistency
Small shade differences can trigger rework or additional coating adjustments. Consistency is particularly important when products are manufactured at multiple sites.
Regulatory change control
A change in raw material, production site, process conditions, particle size, or impurity profile can require customer review and potentially regulatory assessment.
Contamination and elemental impurities
Iron oxide products must be controlled for contaminants such as lead, arsenic, mercury, cadmium, and other elements. Testing expectations are influenced by ICH Q3D principles, pharmacopoeial requirements, and customer-specific limits.
How does ferric oxide red compare with other pharmaceutical colorants?
| Colorant |
Relative maturity |
Main advantage |
Main risk |
| Ferric oxide red |
Very high |
Stable, opaque, low-cost, broad availability |
Shade and impurity control |
| Yellow iron oxide |
Very high |
Commonly paired with red and black oxides |
Heat and shade variation |
| Black iron oxide |
Very high |
Strong opacity and color depth |
Higher risk of formulation color mismatch |
| Titanium dioxide |
Very high |
Strong whitening and opacity |
Regulatory scrutiny in some markets |
| Aluminum lakes |
High |
Bright shades and broad color range |
More complex formulation and regulatory review |
| Synthetic organic dyes |
High |
Bright, intense colors |
Stability and jurisdictional restrictions |
Ferric oxide red remains attractive where manufacturers need muted red, brown, pink, or earth-tone shades, especially in film coatings and capsule shells. Its low cost and established regulatory history support continued use.
What is the investment and commercial outlook?
Ferric oxide red is better viewed as a stable specialty-excipient niche than as a high-growth pharmaceutical market. The strongest commercial positions are likely to belong to suppliers with:
- Pharmaceutical-grade manufacturing and documentation
- Multiple production or inventory locations
- Strong change-control systems
- Technical support for tablet and coating applications
- Broad color portfolios
- Established relationships with generic manufacturers and CDMOs
Revenue growth should come mainly from volume expansion, qualification of premium grades, and modest price increases. Margin expansion will depend on operational efficiency and specialty-grade mix rather than on pharmaceutical exclusivity.
The principal investment risk is overestimating the pharmaceutical share of the overall iron oxide pigment market. Most industry revenue remains exposed to construction, coatings, plastics, and infrastructure cycles. The pharmaceutical segment adds resilience and customer stickiness, but it is unlikely to determine the financial performance of diversified pigment companies.
Key Takeaways
- Ferric oxide red is a mature Fe2O3 pigment used mainly as a pharmaceutical tablet, capsule, and coating colorant.
- The global iron oxide pigment market is measured in billions of dollars, but pharmaceutical-grade ferric oxide red is not separately reported.
- Pharmaceutical demand should grow steadily with generic oral-solid-dose production and contract manufacturing.
- Pricing is limited for standard material but stronger for qualified grades with tight impurity, color, and documentation controls.
- Major suppliers compete on consistency, qualification support, geographic coverage, and supply reliability.
- Ferric oxide red has little standalone patent protection; commercial barriers are based on manufacturing know-how and customer qualification.
- Industrial construction and coatings remain the dominant financial drivers for large pigment producers.
- The base-case financial outlook is stable revenue growth with modest margin expansion for specialty pharmaceutical grades.
FAQs
Is ferric oxide red an active pharmaceutical ingredient?
No. Ferric oxide red is an inactive pharmaceutical ingredient used mainly for coloring, identification, opacity, and appearance control.
Is ferric oxide red the same as CI 77491?
Yes. CI 77491 is the Color Index designation commonly associated with red iron oxide or ferric oxide red.
Can pharmaceutical manufacturers substitute another red pigment?
Often, but not automatically. Substitution may require reformulation, color matching, stability testing, process validation, supplier qualification, and regulatory assessment.
Does ferric oxide red have an Orange Book patent?
Ferric oxide red itself does not ordinarily have an Orange Book patent listing. Patent exposure can arise indirectly through a drug formulation or coating patent that uses the pigment.
Which end market has the greatest effect on ferric oxide red producers?
Construction, coatings, concrete, and plastics generally have a greater effect on producer revenue than pharmaceuticals because they consume much larger pigment volumes.
References
-
European Commission. (n.d.). E172: Iron oxides and hydroxides. European Union food additive database.
-
International Organization for Standardization. (2020). ISO 1248:2020, Iron oxides for paints and extenders: Specifications and methods of test. ISO.
-
U.S. Food and Drug Administration. (2024). Inactive Ingredient Database. https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm
-
U.S. Food and Drug Administration. (2024). 21 C.F.R. § 73.1200: Iron oxides. Electronic Code of Federal Regulations. https://www.ecfr.gov/
-
U.S. Food and Drug Administration. (2022). Q3D(R2) elemental impurities: Guidance for industry. https://www.fda.gov/
-
European Medicines Agency. (2015). ICH Q3D guideline for elemental impurities. https://www.ema.europa.eu/
-
LANXESS. (2024). Bayferrox and inorganic pigments product information. https://www.lanxess.com/
-
Cathay Industries. (2024). Iron oxide pigments product information. https://www.cathayindustries.com/
